Anthropic reports six drug-development partnerships and starts its own discovery programs

Anthropic reports that over several months its scientists have worked with six organizations developing new medicines (BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines and The Column Group) and have begun drug discovery efforts of their own, with technical reports on the case studies. The results are Anthropic's and its partners' own; the post is dated October 27, 2026.